Board Of Directors Member
CurrentFounded in Germany and now headquartered in Orlando, Florida, MEDITE (OTCQB:MDIT) is focused on the development, manufacture and commercialization of molecular biomarkers and high-end medical devices used for the detection, risk assessment, and diagnosis of cancer and precancerous conditions. With revenues of $12 million, MEDITE has established presence in the industry and product distribution into approximately 70 markets worldwide, offering a comprehensive solution cancer diagnostic tools consisting of anatomic pathology, histology and cytology laboratory equipment and supplies.